France Might Block Drugmaker Biogaran’s Sale to Foreign Firm
- Industry minister says drug supply needs to be guaranteed
- State to look at any possible bids for generic-drug company
This article is for subscribers only.
The French government might block a foreign company from buying generic-drug maker Biogaran, Industry Minister Roland Lescure said.
If a foreign buyer wants to acquire Biogaran, France could activate a so-called IEF review, which allows the state to screen and possibly block potential investments by foreign companies in strategic sectors, Lescure told reporters Thursday after inaugurating a factory that makes medical gloves.